Notable News to Watch: Phio Pharmaceuticals Corp. (NASDAQ:PHIO)

On Monday Phio Pharmaceuticals Corp. (NASDAQ:PHIO) stock price moved negative at -26.99%. Its total market capitalization is $3666897. Its day lowest price was $0.12 and its hit its day highest price at $0.16. The stock recent volume is 5063922 shares in comparison to its average trading volume of 297993 shares. Looking at the stock’s price level on the past 52-week graph, PHIO recorded a 52-week high of $0.53 and its 52-week low of $0.12.

On Nov. 18, 2019,  Phio Pharmaceuticals Corp. (NASDAQ:PHIO) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, reported the pricing of its previously announced public offering of 10,000,000 shares of its common stock, at a public offering price per share of $0.10, for gross proceeds of $1.0 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about November 19, 2019,

About Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a biotechnology company developing the next generation of immuno-oncology therapeutics based on its self-delivering RNAi (INTASYL™) therapeutic platform. The Company’s efforts are focused on silencing tumor-induced suppression of the immune system through our proprietary INTASYL™ platform with utility in immune cells and/or the tumor micro-environment. Our goal is to maximize the power of our INTASYL™ therapeutic compounds by weaponizing immune effector cells to overcome tumor immune escape providing patients a powerful new treatment option that goes beyond current treatment modalities.

Leave a Reply

Your email address will not be published. Required fields are marked *